| Announce Date | 11/09/2022 |
| EPS Normalized Actual | $0.1 In Line |
| EPS GAAP Actual | $0.1 In Line |
| Revenue Actual | $115.054B |
| Revenue Surprise | Beat by $115054M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2027 | 183.58869 | 0.09 | 183.58869 | 183.58869 | 1 |
| Jun 2026 | 169.04181 | 0.1 | 169.04181 | 169.04181 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2040.4 | 2040.4 | 115.054B | 21.89% | 115054M |
| FQ2 2025 (Jun 2025) | 2114.3 | 2114.3 | 122.446B | 6.02% | 122446M |
| FQ1 2025 (Mar 2025) | 10337 | 10337 | 105.708B | 42.25% | 105708M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 115.054B | 52.44% | 115054M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 89.873B | 65.81% | 89873M |
| FQ2 2024 (Jun 2024) | 116.07 | 116.07 | 115.08B | 69.23% | 115080M |
| FQ1 2024 (Mar 2024) | -447.84 | -447.84 | 61.044B | 71.82% | 61044M |
| FQ4 2023 (Dec 2023) | 31.35 | 31.35 | 54.722B | 68.56% | 54722M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 0 | -- | 0 | 0 | 0 |
| FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 0 |
| FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 0 |
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 61.85B | -- | 61.85B | 61.85B | 1 |
| FQ2 2028 (Jun 2028) | 70.32B | -- | 70.32B | 70.32B | 1 |
| FQ1 2028 (Mar 2028) | 73.24B | -- | 73.24B | 73.24B | 1 |
| FQ4 2027 (Dec 2027) | 55.46B | -- | 55.46B | 55.46B | 1 |
| FQ3 2027 (Sep 2027) | 47.26B | -- | 47.26B | 47.26B | 1 |
| FQ2 2027 (Jun 2027) | 45B | -- | 45B | 45B | 1 |
| FQ1 2027 (Mar 2027) | 66.53B | -- | 66.53B | 66.53B | 1 |
| FQ4 2026 (Dec 2026) | 48.82B | -- | 48.82B | 48.82B | 1 |
| FQ3 2026 (Sep 2026) | 23.83B | -382.83 | 23.83B | 23.83B | 1 |
| FQ2 2026 (Jun 2026) | 35.98B | -240.32 | 35.98B | 35.98B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2040.4 | 2040.4 | 100% | |
| FQ2 2025 (Jun 2025) | 2114.3 | 2114.3 | 100% | |
| FQ1 2025 (Mar 2025) | 10337 | 10337 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 116.07 | 116.07 | 100% | |
| FQ1 2024 (Mar 2024) | -447.84 | -447.84 | 100% | |
| FQ4 2023 (Dec 2023) | 31.35 | 31.35 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $115.05B | $115054M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $122.45B | $122446M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $105.71B | $105708M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $115.05B | $115054M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $89.87B | $89873M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $115.08B | $115080M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $61.04B | $61044M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $54.72B | $54722M | 100% |